Supriya Lifescience Limited (SUPRIYA.NS)
INR 752.0
(-0.75%)
INR 752.0
(-0.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 5.7 Billion | 4.6 Billion | 5.19 Billion | 3.85 Billion | 3.11 Billion | 2.77 Billion |
| Cost of Revenue | 3.05 Billion | 1.8 Billion | 2.29 Billion | 1.51 Billion | 1.62 Billion | 1.73 Billion |
| Gross Profit | 2.65 Billion | 2.8 Billion | 2.89 Billion | 2.34 Billion | 1.48 Billion | 1.04 Billion |
| Operating Expenses | 1.08 Billion | 1.63 Billion | 873.31 Million | 735.79 Million | 564.45 Million | 432.22 Million |
| Selling, General and Administrative Expenses | 1.08 Billion | 430.93 Million | 361.07 Million | 336.37 Million | 240.18 Million | 183.22 Million |
| Research and Development Expenses | - | 12.37 Million | 16.62 Million | 6.61 Million | 10.57 Million | 7.78 Million |
| Other Expenses | - | 94.89 Million | 110 Thousand | 39.69 Million | 83.55 Million | 48.14 Million |
| Cost and Expenses | 4.13 Billion | 3.43 Billion | 3.17 Billion | 2.24 Billion | 2.19 Billion | 2.16 Billion |
| Operating Income | 1.57 Billion | 1.17 Billion | 2.04 Billion | 1.66 Billion | 1 Billion | 610.98 Million |
| Interest Expense | 37.03 Million | 30.84 Million | 28.11 Million | 40.8 Million | 68.49 Million | 102.22 Million |
| Income Tax Expense | 465.76 Million | 336.3 Million | 554.35 Million | 435.65 Million | 228.24 Million | 176.79 Million |
| Earnings before Tax | 1.65 Billion | 1.23 Billion | 2.07 Billion | 1.67 Billion | 962.27 Million | 571.04 Million |
| Net Income | 1.19 Billion | 898.57 Million | 1.51 Billion | 1.23 Billion | 734.03 Million | 394.24 Million |
| Earnings Per Share Basic | 14.80 | 11.16 | 18.86 | 16.89 | 10.03 | 15.43 |
| Earnings Per Share Diluted | 14.80 | 11.16 | 18.86 | 16.89 | 10.03 | 15.43 |
| Weighted Average Shares Outstanding | 80.48 Million | 80.48 Million | 80.48 Million | 73.18 Million | 73.18 Million | 25.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 80.48 Million | 80.48 Million | 80.48 Million | 73.18 Million | 73.18 Million | 25.54 Million |
| Gross Margin | 0.46 | 0.61 | 0.56 | 0.61 | 0.48 | 0.38 |
| EBIT Margin | 0.32 | 0.30 | 0.42 | 0.46 | 0.35 | 0.25 |
| Profit Margin | 0.21 | 0.19 | 0.29 | 0.32 | 0.24 | 0.14 |
| EBITDA | 1.83 Billion | 1.38 Billion | 2.21 Billion | 1.78 Billion | 1.08 Billion | 724.67 Million |
| Earnings Before Tax Margin | 0.28 | 0.25 | 0.39 | 0.43 | 0.32 | 0.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.66 Billion | 1.6 Billion | 5.7 Billion | 1.58 Billion | 1.4 Billion | 1.4 Billion |
| Cost of Revenue | 459.75 Million | 733.37 Million | 3.05 Billion | 793.19 Million | 546.21 Million | 616.39 Million |
| Gross Profit | 1.2 Billion | 872.89 Million | 2.65 Billion | 788.61 Million | 854.53 Million | 784.56 Million |
| Operating Expenses | 601.54 Million | 294.03 Million | 1.08 Billion | 272.71 Million | 479.24 Million | 506.85 Million |
| Selling, General and Administrative Expenses | 357.25 Million | 294.03 Million | - | 272.71 Million | 264 Million | 292.02 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 601.54 Million | 22.24 Million | 106.35 Million | 21.85 Million | 30.65 Million | 24.67 Million |
| Cost and Expenses | 1.06 Billion | 1.02 Billion | 4.13 Billion | 1.06 Billion | 1.02 Billion | 1.12 Billion |
| Operating Income | 599.73 Million | 578.86 Million | 1.57 Billion | 515.9 Million | 405.93 Million | 302.38 Million |
| Interest Expense | 4.27 Million | 3.35 Million | 21.1 Million | 6.01 Million | 4.94 Million | 4.6 Million |
| Income Tax Expense | 159.15 Million | 151.31 Million | 465.76 Million | 162.43 Million | 103.12 Million | 58.94 Million |
| Earnings before Tax | 620.64 Million | 597.74 Million | 1.65 Billion | 531.75 Million | 400.99 Million | 297.78 Million |
| Net Income | 461.49 Million | 446.44 Million | 1.19 Billion | 369.32 Million | 297.87 Million | 238.84 Million |
| Earnings Per Share Basic | 5.71 | 5.55 | - | 4.59 | 3.70 | 2.97 |
| Earnings Per Share Diluted | 5.71 | 5.55 | - | 4.59 | 3.70 | 2.97 |
| Weighted Average Shares Outstanding | 80.82 Million | 80.48 Million | 80.48 Million | 80.46 Million | 80.48 Million | 80.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 80.82 Million | 80.48 Million | 80.48 Million | 80.46 Million | 80.48 Million | 80.48 Million |
| Gross Margin | 0.72 | 0.54 | 0.46 | 0.50 | 0.61 | 0.56 |
| EBIT Margin | 0.40 | 0.39 | - | 0.35 | 0.32 | 0.24 |
| Profit Margin | 0.28 | 0.28 | 0.21 | 0.23 | 0.21 | 0.17 |
| EBITDA | 672.35 Million | 625.42 Million | - | 555.04 Million | 445.53 Million | 342.19 Million |
| Earnings Before Tax Margin | 0.36 | 0.36 | 0.28 | 0.33 | 0.29 | 0.22 |
ELECON
CSR
TKT
AMBO
EUX
KAMDHENU